{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:41:30Z","timestamp":1790613690183,"version":"4.1.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00341","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T23:55:18Z","timestamp":1582674918000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":82,"title":["IL-17C\/IL-17RE: Emergence of a Unique Axis in TH17 Biology"],"prefix":"10.3389","volume":"11","author":[{"given":"Jasper F.","family":"Nies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Panzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","article-title":"Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis","volume":"373","author":"Mease","year":"2015","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","article-title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"McInnes","year":"2015","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis\u2013results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13447","DOI":"10.1074\/jbc.M700499200","article-title":"Identification of an interleukin 17F\/17A heterodimer in activated human CD4+ T cells","volume":"282","author":"Wright","year":"2007","journal-title":"J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/cr.2007.35","article-title":"A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses","volume":"17","author":"Chang","year":"2007","journal-title":"Cell Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting edge: interleukin 17 signals through a heteromeric receptor complex","volume":"177","author":"Toy","year":"2006","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.4049\/jimmunol.181.6.4299","article-title":"Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities","volume":"181","author":"Rickel","year":"2008","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/ni.2155","article-title":"IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens","volume":"12","author":"Song","year":"2011","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.4049\/jimmunol.1800696","article-title":"Cutting edge: IL-17B uses IL-17RA and IL-17RB to induce Type 2 inflammation from human lymphocytes","volume":"202","author":"Ramirez-Carrozzi","year":"2019","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"eaau9657","DOI":"10.1126\/sciimmunol.aau9657","article-title":"Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation","volume":"4","author":"Su","year":"2019","journal-title":"Sci Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1073\/pnas.97.2.773","article-title":"Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1172\/JCI63681","article-title":"IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis","volume":"123","author":"Huber","year":"2013","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.immuni.2009.06.020","article-title":"Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals","volume":"31","author":"Martin","year":"2009","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.4049\/jimmunol.178.7.4466","article-title":"Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production","volume":"178","author":"Shibata","year":"2007","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1084\/jem.20061551","article-title":"Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia","volume":"204","author":"Michel","year":"2007","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.20072713","article-title":"Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22","volume":"206","author":"Takatori","year":"2009","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.2569","article-title":"Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells","volume":"14","author":"Bermejo","year":"2013","journal-title":"Nat Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ni.2156","article-title":"IL-17C regulates the innate immune function of epithelial cells in an autocrine manner","volume":"12","author":"Ramirez-Carrozzi","year":"2011","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/jop.12095","article-title":"IL-17C and its receptor IL-17RA\/IL-17RE identify human oral epithelial cell as an inflammatory cell in recurrent aphthous ulcer","volume":"43","author":"Al-Samadi","year":"2014","journal-title":"J Oral Pathol Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1084\/jem.20160581","article-title":"Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation","volume":"214","author":"Peng","year":"2017","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1365-2133.2010.10036.x","article-title":"Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNF\u03b1 therapy","volume":"163","author":"Johansen","year":"2010","journal-title":"Br J Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"25487","DOI":"10.1074\/jbc.M111.240671","article-title":"Tumor necrosis factor \u03b1-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor \u03baB","volume":"286","author":"Johansen","year":"2011","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1681\/ASN.2017090949","article-title":"IL-17C\/IL-17 receptor E Signaling in CD4(+) T cells promotes TH17 cell-driven glomerular inflammation","volume":"29","author":"Krohn","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/cmi.2015.56","article-title":"IL-17C is required for lethal inflammation during systemic fungal infection","volume":"13","author":"Huang","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"L1015","DOI":"10.1152\/ajplung.00158.2016","article-title":"IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia","volume":"311","author":"Wolf","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1165\/rcmb.2012-0232OC","article-title":"IL-17C is a mediator of respiratory epithelial innate immune response","volume":"48","author":"Pfeifer","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1165\/rcmb.2013-0130OC","article-title":"Toll-like receptor-mediated airway IL-17C enhances epithelial host defense in an autocrine\/paracrine manner","volume":"50","author":"Kusagaya","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00264-013-1812-x","article-title":"Presence of interleukin-17C in the tissue around aseptic loosened implants","volume":"37","author":"Hou","year":"2013","journal-title":"Int Orthop"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.4049\/jimmunol.179.10.7128","article-title":"IL-17B and IL-17C are associated with TNF-\u03b1 production and contribute to the exacerbation of inflammatory arthritis","volume":"179","author":"Yamaguchi","year":"2007","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1161\/ATVBAHA.116.307892","article-title":"Smooth muscle cell-derived interleukin-17C plays an atherogenic role via the recruitment of proinflammatory interleukin-17A+ T cells to the aorta","volume":"36","author":"Butcher","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.chom.2008.09.009","article-title":"Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine","volume":"4","author":"Ivanov","year":"2008","journal-title":"Cell Host Microbe"},{"key":"B33","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature07240","article-title":"ATP drives lamina propria T(H)17 cell differentiation","volume":"455","author":"Atarashi","year":"2008","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2009.08.020","article-title":"The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses","volume":"31","author":"Gaboriau-Routhiau","year":"2009","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.1206095","article-title":"The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota","volume":"332","author":"Round","year":"2011","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.immuni.2016.10.020","article-title":"Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney","volume":"45","author":"Krebs","year":"2016","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.immuni.2013.11.018","article-title":"Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis","volume":"40","author":"Song","year":"2014","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.cellsig.2005.10.010","article-title":"Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras\/mitogen-activated protein kinase signaling pathway","volume":"18","author":"Li","year":"2006","journal-title":"Cell Signal"},{"key":"B40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.immuni.2011.09.010","article-title":"Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E","volume":"35","author":"Chang","year":"2011","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.4049\/jimmunol.1103014","article-title":"Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C","volume":"189","author":"Reynolds","year":"2012","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/422329","article-title":"Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice","volume":"190","author":"Huang","year":"2004","journal-title":"J Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0122807","DOI":"10.1371\/journal.pone.0122807","article-title":"Signaling through IL-17C\/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis","volume":"10","author":"Conti","year":"2015","journal-title":"PLoS ONE"},{"key":"B46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4049\/jimmunol.1800547","article-title":"Rhinovirus and bacteria synergistically induce IL-17C release from human airway epithelial cells to promote neutrophil recruitment","volume":"202","author":"Jamieson","year":"2019","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","article-title":"Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin","volume":"160","author":"Johansen","year":"2009","journal-title":"Br J Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","article-title":"Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation","volume":"190","author":"Johnston","year":"2013","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/jid.2012.318","article-title":"An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling","volume":"133","author":"El Malki","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.jid.2018.01.036","article-title":"Neutralization of IL-17C reduces skin inflammation in mouse models of psoriasis and atopic dermatitis","volume":"138","author":"Vandeghinste","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"669","DOI":"10.4049\/jimmunol.1600977","article-title":"IL-17C\/IL-17RE augments T cell function in autoimmune hepatitis","volume":"198","author":"Huang","year":"2017","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"15750","DOI":"10.1038\/s41598-018-34054-x","article-title":"The roles of IL-17C in T cell-dependent and -independent inflammatory diseases","volume":"8","author":"Yamaguchi","year":"2018","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1097\/MIB.0000000000000198","article-title":"IL-36gamma sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease","volume":"20","author":"Friedrich","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1038\/onc.2017.28","article-title":"IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth","volume":"36","author":"Jungnickel","year":"2017","journal-title":"Oncogene"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-9966-32-3","article-title":"High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma","volume":"32","author":"Liao","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"10353","DOI":"10.1038\/s41598-019-46759-8","article-title":"IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer","volume":"9","author":"Ritzmann","year":"2019","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0968-0004(03)00067-7","article-title":"The STIR-domain superfamily in signal transduction, development and immunity","volume":"28","author":"Novatchkova","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","article-title":"Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor","volume":"3","author":"Yao","year":"1995","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","first-page":"14088","DOI":"10.1074\/jbc.M109.017129","article-title":"Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-\u03b1 is controlled by I\u03baB-zeta but neither by C\/EBP-beta nor C\/EBP-delta","volume":"285","author":"Karlsen","year":"2010","journal-title":"J Biol Chem"},{"key":"B60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni1439","article-title":"The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease","volume":"8","author":"Qian","year":"2007","journal-title":"Nat Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ni.2080","article-title":"The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation","volume":"12","author":"Bulek","year":"2011","journal-title":"Nat Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"ra24","DOI":"10.1126\/scisignal.aaa2147","article-title":"Control of IL-17 receptor signaling and tissue inflammation by the p38\u03b1-MKP-1 signaling axis in a mouse model of multiple sclerosis","volume":"8","author":"Huang","year":"2015","journal-title":"Sci Signal"},{"key":"B63","doi-asserted-by":"publisher","first-page":"35603","DOI":"10.1074\/jbc.C600256200","article-title":"Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor","volume":"281","author":"Chang","year":"2006","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1074\/jbc.M308809200","article-title":"Functional cooperation between interleukin-17 and tumor necrosis factor-\u03b1 is mediated by CCAAT\/enhancer-binding protein family members","volume":"279","author":"Ruddy","year":"2004","journal-title":"J Biol Chem"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.1073\/pnas.0611589104","article-title":"Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression","volume":"104","author":"Maitra","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B66","doi-asserted-by":"publisher","first-page":"ra8","DOI":"10.1126\/scisignal.2000066","article-title":"IL-17 receptor signaling inhibits C\/EBPbeta by sequential phosphorylation of the regulatory 2 domain","volume":"2","author":"Shen","year":"2009","journal-title":"Sci Signal"},{"key":"B67","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.4049\/jimmunol.179.6.4135","article-title":"IL-17 enhances chemokine gene expression through mRNA stabilization","volume":"179","author":"Hartupee","year":"2007","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ni.2081","article-title":"Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)","volume":"12","author":"Sun","year":"2011","journal-title":"Nat Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/jid.2013.313","article-title":"The pattern recognition receptor NOD2 mediates Staphylococcus aureus-induced IL-17C expression in keratinocytes","volume":"134","author":"Roth","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.4049\/jimmunol.1301737","article-title":"Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody","volume":"192","author":"Russell","year":"2014","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4049\/jimmunol.1601551","article-title":"MCPIP1\/regnase-1 restricts IL-17A- and IL-17C-dependent skin inflammation","volume":"198","author":"Monin","year":"2017","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nature07924","article-title":"Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay","volume":"458","author":"Matsushita","year":"2009","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1084\/jem.20092641","article-title":"MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-\u03baB signaling","volume":"207","author":"Liang","year":"2010","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.immuni.2015.07.021","article-title":"MCPIP1 endoribonuclease activity negatively regulates interleukin-17-mediated signaling and inflammation","volume":"43","author":"Garg","year":"2015","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2013.04.034","article-title":"Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation","volume":"153","author":"Uehata","year":"2013","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2165\/11207530-000000000-00000","article-title":"Ustekinumab: a review of its use in the management of moderate to severe plaque psoriasis","volume":"71","author":"Croxtall","year":"2011","journal-title":"Drugs"},{"key":"B78","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","article-title":"Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial","volume":"382","author":"McInnes","year":"2013","journal-title":"Lancet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn's disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N Engl J Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(15)60125-8","article-title":"Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials","volume":"386","author":"Griffiths","year":"2015","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMoa1503824","article-title":"Phase 3 studies comparing brodalumab with ustekinumab in psoriasis","volume":"373","author":"Lebwohl","year":"2015","journal-title":"N Engl J Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/S0140-6736(18)31946-9","article-title":"Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial","volume":"392","author":"van der Heijde","year":"2018","journal-title":"Lancet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"B84","unstructured":"GlobeNewswireInc\n          Galapagos and Morphosys Report First Promising Signs of Clinical Activity in a Phase 1 Study with IL-17c Antibody Mor106 in Atopic Dermatitis Patients2017"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/ajg.2016.298","article-title":"A randomized, double-blind, placebo-controlled phase 2 study of brodalumab in patients with moderate-to-severe Crohn's disease","volume":"111","author":"Targan","year":"2016","journal-title":"Am J Gastroenterol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00341\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T23:55:22Z","timestamp":1582674922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00341\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":86,"alternative-id":["10.3389\/fimmu.2020.00341"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00341","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]},"article-number":"341"}}